Answers are grounded in this paper and cite their sources.
Demonstrates a novel organophotoredox catalyst for efficient coupling reactions with aryl halides, implying potential for advanced synthetic applications.
Phenoxazine-based organophotoredox catalyst PC-A was prepared using a two-step process starting from 2-(3,5-di-tert-butyl-2hydroxyphenylamino)benzonitrile, with a catalytic amount of MnCl2•4H2O, and finally by substituting the NH proton of the phenoxazine moiety...
No takes yet. Share an insight, caveat, or question.
Das et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: